With metastasectomy being increasingly offered to patients with oligometastatic recurrence of PCa, a need exists to assess the diagnostic performance of 68Ga-PSMA-11 PET/CT in patients with higher PSA levels (up to 10 ng/mL) who may have a more widespread pattern of recurrence. Here, FOLH1 is linked to posterior cortical atrophy.